| Monday 7 April
|
|
09.00 onwards
|
|
Registration
Main Foyer
|
| |
|
|
|
10.30 12.30
|
|
Bone and Mineral Special Interest Group Satellite: Osteoporosis
In association with the National Osteoporosis Society
Generously supported by Novartis & Roche
Queen's Suite 2
Chairs: J Wass (Oxford) & R Eastell (Sheffield)
|
| 10.30 |
|
Reception
|
| 11.00 |
|
Chairman's introduction: osteoporosis - the silent epidemic?
J Wass (Oxford) & R Eastell (Sheffield)
|
| 11.10 |
|
NICE ways to manage osteoporosis
P Selby (Manchester)
|
| 11.30 |
|
'But doctor I can't take generic alendronic acid!'
R Eastell (Sheffield)
|
| 11.50 |
|
'But doctor no guidelines apply to my situation'
S Orme (Leeds)
|
| 12.10 |
|
So you want to set up an osteoporosis service?
A McLellan (Glasgow)
|
| |
|
|
|
10.30 12.30
|
|
Andrology Special Interest Group Satellite: Controversies in the diagnosis and management of hypogonadism
Generously supported by Bayer Schering Pharma & ProStrakan
Queen's Suite 1
Chair: H Jones (Sheffield)
|
| 10.30 |
|
Hypogonadism and diabetes
H Jones (Sheffield)
|
| 10.50 |
|
Aging, frailty and testosterone
F Wu (Manchester)
|
| 11.10 |
|
Difficulties in the diagnosis of hypogonadism
S Arver (Stockholm, Sweden)
|
| 11.30 |
|
Testosterone and prostate safety
M Feneley (London)
|
| 11.50 |
|
Discussion
|
| |
|
|
|
12.30 13.00
|
|
Lunch
Hall Q
|
| |
|
|
|
13:00 15:00
|
|
Symposium 1: New twists in appetite/satiety signalling pathways
King's Suite
Chairs: S O'Rahilly (Cambridge) & K Smith (London)
|
| 13.00 |
S9
|
Plasma triglycerides and appetite control
W Banks (St Louis, USA)
|
| 13.30 |
S10
|
Imaging the brain appetite network
S Luckman (Manchester)
|
| 14.00 |
S11
|
Role of central serotonin 2C receptors in appetite control
L Heisler (Cambridge)
|
| 14.30 |
S12
|
Central role of AMP-Kinase in appetite control
M Korbonits (London)
|
| |
|
|
|
13:00 15:00
|
|
Clinical Management Workshop 1: Fibrous dysplasia and McCune-Albright syndrome
Supported by Clinical Endocrinology
Main Auditorium
Chairs: R Thakker (Oxford) & M Cooper (Birmingham)
|
| 13.00 |
S44
|
The endocrine consequences of McCune-Albright syndrome
P Trainer (Manchester)
|
| 13.40 |
S45
|
Molecular genetics and cell biology of McCune-Albright syndrome and fibrous dysplasia
L Weinstein (Bethesda, USA)
|
| 14.20 |
S46
|
Medical treatment of fibrous dysplasia of bone
R Chapurlat (Lyon, France)
|
| |
|
|
|
13:00 15:00
|
|
Molecular Endocrinology Workshop
Queen's Suite 1
Chairs: M Gurnell (Cambridge) & K Boelaert (Birmingham)
|
| 13.00 |
S70
|
Cell metabolomics: differential metabolism of glucose and fructose in pancreatic cancer
T Heaney (Los Angeles, USA)
|
| 14.00 |
S71
|
Combining mouse genetics, transgenics and knockouts to explore the biology of MC1R aganism and antagonism
I Jackson (Edinburgh)
|
| |
|
|
|
15:00 15:30
|
|
Coffee
Hall Q
|
| |
|
|
|
15:30 17:30
|
|
Symposium 2: System-specific effect steroids
King's Suite
Chairs: S Lightman (Bristol) & G Lavery (Birmingham)
|
| 15.30 |
S13
|
Glucocorticoid signalling in the brain
S Lightman (Bristol)
|
| 16.00 |
S14
|
Glucocorticoids, 11beta HSDs and neuroprotection
M Holmes (Edinburgh)
|
| 16.30 |
S15
|
Glucocorticoids, liver, fat and metabolic syndrome
P Stewart (Birmngham)
|
| 17.00 |
S16
|
Glucocorticoids, folliculo-stellate cells and the pituitary
H Christian (Oxford)
|
| |
|
|
|
15:30 17:30
|
|
Oral Communications 1: Young Endocrinologists Prize Session
Main Auditorium
Chairs: J Wass (Oxford) & A McNeilly (Edinburgh)
|
| 15.30 |
OC1
|
Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B gene mutation carriers
U Srirangalingam;
L Walker;
B Khoo;
F MacDonald;
D Gardner;
T Wilkin;
R Skelly;
E George;
D Spooner;
J Monson;
A Grossman;
S Akker;
P Pollard;
N Plowman;
N Avril;
D Berney;
J Burrin;
R Reznek;
V Kumar;
E Maher;
S Chew;
|
| 15.45 |
OC2
|
The ghrelin-cannabinoid axis – a novel pathway in the regulation of appetite and metabolism
F Amin;
B Kola;
M Christ-Crain;
F Lolli;
G Wittmann;
J Harvey-White;
G Kunos;
A Grossman;
C Fekete;
M Korbonits;
|
| 16.00 |
OC3
|
Does 11beta-HSD1 in visceral adipose tissue (VAT) deliver cortisol to the liver? Studies with portal vein sampling and tracer infusion in humans.
R Stimson;
R Andrew;
D Redhead;
P Hayes;
B Walker;
|
| 16.15 |
OC4
|
Hypoxia and GC signalling regulate macrophage migration inhibitory factor (MIF) gene expression through a common element
L Elsby;
R Donn;
Z Alourfi;
E Beaulieu;
D Ray;
|
| 16.30 |
OC5
|
Placental vascular development and nutrient transport in 11ß-HSD2-/-mice
C Wyrwoll;
J Seckl;
M Holmes;
|
| 16.45 |
OC6
|
MRAP2 permits the functional expression of the melanocortin-2-receptor: a new member of a new family of melanocortin receptor accessory proteins
L Chan;
L Metherell;
M Elphick;
J Chapple;
A Clark;
|
| 17.00 |
OC7
|
Testosterone treatment improves muscle strength, lean mass and quality of life in prefrail and frail elderly men: Results from a randomised double-blind placebo-controlled study
U Srinivas-Shankar;
S Roberts;
J Adams;
M Connolly;
J Oldham;
F Wu;
|
| 17.15 |
OC8
|
β-cell 11β-Hydroxysteroid dehydrogenase type 1 contributes to Type 2 Diabetes.
S Turban;
L Ramage;
J Paterson;
J Mullins;
J Seckl;
N Morton;
|
| |
|
|
|
15:30 17:30
|
|
Oral Communications 2: Reproduction
Queen's Suite 1
Chairs: H Critchley (Edinburgh) & J Prague (London)
|
| 15.30 |
OC9
|
Dynamic responses of oestrogen receptors revealed by fluorescent recovery after photobleaching (FRAP)
C Fitzgerald;
F Collins;
P Brown;
V Bombail;
K Kerr;
S Macpherson;
M Millar;
P Saunders;
|
| 15.45 |
OC10
|
Expression of somatostatin receptors 1-5 in normal human endometrium through the menstrual cycle
E Dickerson;
K Bedford;
I Richmond;
S Maguiness;
J Robinson;
S Xu;
S Atkin;
|
| 16.00 |
OC11
|
Identification of a novel compound heterozygous mutation in the gonadotrophin releasing hormone receptor in two siblings with isolated hypogonadotrophic hypogonadism
A Chesover;
S Kim;
J Ahlquist;
P Bouloux;
|
| 16.15 |
OC12
|
Modelling Kallmann's Syndrome in the zebrafish
S Cadman;
G Philp;
S Kim;
P Bouloux;
I Mason;
|
| 16.30 |
OC13
|
Effect of hypoxia and inflammatory and anti-inflammatory signals on gene expression in sheep ovarian surface epithelium (OSE) in vitro.
C Harlow;
M Rae;
D Price;
A McNeilly;
S Rhind;
S Hillier;
|
| 16.45 |
OC14
|
IGF-mediated cell turnover in the human placenta is positively regulated by the protein tyrosine phosphatase, SHP-2.
K Forbes;
J Aplin;
M Westwood;
|
| 17.00 |
OC15
|
Evaluation of the prevalence of vitamin D deficiency and its treatment in a west London pregnant population
H Salmasi;
A Banerjee;
M Donaldson;
A Wren;
|
| 17.15 |
OC16
|
Enhanced hypothalamic-pituitary-adrenal axis activation, 5α-reductase activity and insulin resistance distinguishes polycystic ovary syndrome from simple obesity
D Vassiliadi;
J Tomlinson;
B Hughes;
C Gay;
S Sira;
P Nightingale;
C Shackleton;
P Stewart;
W Arlt;
|
| |
|
|
|
17:30 17:45
|
|
Tea
Hall Q
|
| |
|
|
|
17:45 18:45
|
|
Young Endocrinologist Prize Lectures
Main Auditorium
Chairs: P Stewart (Birmingham) & A McNeilly (Edinburgh)
|
| 17.45 |
S64
|
Peptide YY: Food for thought
R Batterham (London)
|
| 18.15 |
S65
|
11b-HSD1 and metabolic disease: a mouses’ Tail
N Morton (Edinburgh)
|
| |
|
|
|
18:45 onwards
|
|
Welcome Reception
Holiday Inn
|
| |
|
|
|
19:45 onwards
|
|
Young endocrinologists quiz night
Generously supported by Fisher Scientific & Novo Nordisk Ltd
Hall D
|
| |
|
|